Ureteral smooth muscle contraction pathways

Ureteral smooth muscle contraction pathways refer to the integrated molecular signaling systems responsible for the rhythmic peristaltic contractions of the ureter, which facilitate the transport of urine from the renal pelvis to the urinary bladder (NIH, 2024). These pathways are primarily regulated by the autonomic nervous system and local myogenic factors, with key molecular players including alpha-1 adrenergic receptors (specifically alpha-1D and alpha-1A subtypes), voltage-gated L-type calcium channels, and Rho-kinase (ROCK) (StatPearls, 2023; NIH, 2024). Activation of alpha-1 receptors leads to Gq-protein-mediated phospholipase C activation and subsequent increases in intracellular calcium, while ROCK contributes to calcium sensitization of the contractile apparatus (NIH, 2024). Pharmacological targeting of these pathways is clinically significant in the management of urolithiasis and renal colic; for instance, alpha-1 adrenoceptor antagonists like tamsulosin and calcium channel blockers like nifedipine are utilized in medical expulsion therapy to relax ureteral smooth muscle and promote stone passage (StatPearls, 2023). Understanding these pathways is essential for developing treatments for ureteral dysfunction, including obstructive uropathy and congenital conditions like megaureter (NIH, 2024).

Other names

Ureteral peristalsis pathwaysUreteral contractility signalingUreteral smooth muscle signalingUreteric smooth muscle contraction

The pathways are modulated through the antagonism of alpha-1 adrenergic receptors (primarily alpha-1D and alpha-1A) to decrease muscle tone, the blockade of L-type voltage-gated calcium channels to inhibit contraction, and the activation of beta-3 adrenergic receptors to induce relaxation. Other mechanisms include the inhibition of phosphodiesterase enzymes (PDE4 and PDE5) to increase intracellular cAMP and cGMP, and the inhibition of Rho-kinase (ROCK) to reduce calcium sensitization of the contractile machinery (NIH, 2024; StatPearls, 2023).